Nothing Special   »   [go: up one dir, main page]

Keddie et al., 2018 - Google Patents

Clinical perspectives into the use of thalidomide for central nervous system tuberculosis

Keddie et al., 2018

View PDF
Document ID
16337577066949117544
Author
Keddie S
Bharambe V
Jayakumar A
Shah A
Sanchez V
Adams A
Gnanapavan S
Publication year
Publication venue
European Journal of Neurology

External Links

Snippet

Background and purpose Central nervous system (CNS) tuberculosis (TB) accounts for over 4% of all TB notifications in the UK and causes death or significant disability in over half of those affected. Tumour necrosis factor alpha is a critical cytokine involved in the …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Similar Documents

Publication Publication Date Title
Keddie et al. Clinical perspectives into the use of thalidomide for central nervous system tuberculosis
Arditi et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use
Marx et al. Tuberculous meningitis: diagnosis and treatment overview
Heckenberg et al. Adjunctive dexamethasone in adults with meningococcal meningitis
Fallon et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy
Whitley et al. Herpes simplex encephalitis: vidarabine therapy and diagnostic problems
Mandalakas et al. Current concepts of childhood tuberculosis
Meisenheimer et al. Acute diarrhea in adults
Khurana et al. Central nervous system infection with Acanthamoeba in a malnourished child
Unal et al. Clinical and radiological features of symptomatic central nervous system tuberculomas
Sridhar et al. Fatal anti-aquaporin-4 seropositive neuromyelitis optica spectrum disorder in tuberculosis
Kermansaravi et al. Evaluation of active pulmonary tuberculosis among patients with diabetes
Tiffany et al. Improved neurodevelopmental outcomes following long-term high-dose oral acyclovir therapy in infants with central nervous system and disseminated herpes simplex disease
Kimberlin Diagnosis of herpes simplex virus in the era of polymerase chain reaction
de la Riva et al. Clinical response to thalidomide in the treatment of intracranial tuberculomas: case report
Zhao et al. Induction therapy with high‐dose fluconazole plus flucytosine for human immunodeficiency virus‐uninfected cryptococcal meningitis patients: Feasible or not?
Chesdachai et al. Diagnostic challenges and dilemmas in tuberculous meningitis
Lau et al. A registry of tuberculous meningitis in Hong Kong
Kowalsky et al. Bacterial Meningitis Post–PCV7: Declining Incidence and Treatment
Tan et al. A rare case of lymphadenitis and pulmonary disease caused by Mycobacterium paraffinicum
Yuan et al. Candida meningitis in an infant after abdominal surgery successfully treated with intrathecal and intravenous amphotericin B: A case report
Yang et al. A case of tuberculosis-associated acute disseminated encephalomyelitis in a seven-month-old infant
Boguniewicz et al. Management of Extensive Central Nervous System Cladophialophora bantiana Infection in a 9-Year-Old Child
Swain et al. Tubercular optochiasmatic arachnoiditis: A case report with current therapeutics and management
Dauby et al. Prevalence, risk factors, and serotype distribution of group B Streptococcus colonization in HIV-infected pregnant women living in Belgium: a prospective cohort study